Kazakhstan

  • Activities have included collaborations with the Ministry of Health assessed the outcome of HIV and Tuberculosis treatment among co-infected patients
  • Studies have explored the association between antiretroviral therapy and antitubercular drug resistance in TB treatment outcome among Kazakh TB/HIV co-infected patients. 
  • As a resulting academic article observes
    • Drug-resistant tuberculosis (TB) poses a serious threat to public health in Kazakhstan. This paper presents findings related to TB treatment outcome and drug resistance status among people co-infected with human immunodeficiency virus (HIV) and TB in Kazakhstan.
    • A cohort study using data provided by the Kazakhstan Ministry of Health's National Tuberculosis Program for 2014 and 2015 was performed to understand factors associated with drug-resistant TB status and TB treatment outcome.
    • These results suggest that having drug-resistant TB is associated with a higher likelihood of completing treatment with successful outcome, even when controlling for receipt of ARV therapy.